about
Correlates of Protection for M Protein-Based Vaccines against Group A StreptococcusImpaired Antigen-Specific Immune Response to Vaccines in Children with Antibody Production DefectsA review of invasive Haemophilus influenzae disease in the Indigenous populations of North America.Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.Progress in vaccination against Haemophilus influenzae type b in the Americas.The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinantImmunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis.Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Activation of innate immune responses by Haemophilus influenzae lipooligosaccharideBronchiectasis in Children: Current Concepts in Immunology and MicrobiologyThe causative organisms of bacterial meningitis in Korean children in 1996-2005.Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infantsComparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Can successful vaccines teach us how to induce efficient protective immune responses?Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine boosterTranslating tumor antigens into cancer vaccinesNaturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, CanadaTwo or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trialsDirect Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.A launch vector for the production of vaccine antigens in plants.Prevention of Haemophilus influenzae type b disease: past success and future challenges.Particle-based platforms for malaria vaccines.Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.The love-hate relationship between bacterial polysaccharides and the host immune system.The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine.Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates.Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United KingdomNeonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines.Expanding prevention of invasive meningococcal disease.The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal CarriagePediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents.Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature.Invasive Haemophilus influenzae disease in the vaccine era in Rio de Janeiro, Brazil.The continuing role of Haemophilus influenzae type b carriage surveillance as a mechanism for early detection of invasive disease activity.Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trialsMenACWY-TT vaccine for active immunization against invasive meningococcal disease.CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.
P2860
Q27009175-5252AF04-6B96-4FF4-844C-2017F623B2A5Q28384666-D3320ECC-0245-40E9-ABC4-4544D1183B16Q30217185-35DEA5F0-AFAC-4F0A-9E56-411D3387722BQ30370370-483F5CFC-EF20-4B67-8AB5-D06F054F7C25Q33330445-92DF2029-D893-4ACD-A05C-C91DEDD886E6Q33447018-1ACC50FE-51A8-449A-91CA-4A7BB6A09578Q33565405-B855CF5A-8005-4CFD-9B58-C4B358D5386BQ33591243-511D618F-EB9F-421E-8C5E-E41C5C97BDC4Q33601866-3F30A7EB-6E68-40AE-8DCA-F0548EFB5837Q33734772-F418D6DB-2B6C-4C49-B593-523728ED8A6FQ33879697-155EF313-ED55-46F4-80B6-0EE230D1AD02Q33937355-C71A667B-8AA9-49EE-85DB-AC643C6CCF8AQ34033168-0C7F5783-821B-4664-BA2E-E6FADF0E9C67Q34034071-4801F684-9D18-4C26-A83D-C8F71B2ADFC3Q34170021-62ADEB4F-7F34-4823-A9BA-3E7F8922D595Q34409182-0B2B39BF-7CFE-4637-8B41-D30961F2017DQ34431928-EFC7C4F7-95C0-4B04-B0EA-93298B327E8DQ34484042-BA3306B1-4965-445A-88A8-8F877CEE7F82Q35037371-E23C3171-DA2C-4DEF-9DEF-A990CF2B7445Q35528932-2E258786-4CAA-4983-A249-5E3DC851D137Q35867061-28E3A7A9-1DBC-47AD-9CFD-98720BFA1A9EQ36252789-F4EAC212-FA56-4901-BFAB-420A5FA74CEFQ36350560-36187775-BF3B-4A25-AAB7-B726C2B9B175Q36396040-85BB6AF8-31C0-4C35-BA45-35F1AD038BD8Q36452316-C4C970F7-66C0-482B-B138-ADA6F6DC6E79Q36615936-F6D1D9BE-47C5-4168-B442-06EC7A1B0A09Q36688241-24946067-003D-4E97-9A93-16973326BECBQ37077660-75938BD9-DD6D-4531-969C-577D6783D3A0Q37099250-36896E5A-271A-4F33-AEFC-5CD842EF3BB9Q37282316-27B0BC5F-5B0E-44BD-86EB-5961FDCC5860Q37503239-51C9FCB8-D721-4B7E-A24F-9310917BD657Q37504676-4411538D-351E-49C3-A7CD-2E3E5B350590Q37559933-5AB82C22-7FAF-487C-BDF4-31F770284F0CQ37562992-CC66816B-D194-48A7-9C0F-64CEE2A3F82AQ37577895-BD4B591D-6050-4062-A302-1E703ED8CB7FQ37656004-2FEFEEB4-4C63-4D34-9D57-54B0892A0352Q37959649-C81B6BED-41BF-449C-9D27-700ED82F7ED3Q38009929-121FF013-1857-48CF-BF20-DDB3AAD77F3DQ38028992-073A8DFB-B3BF-4F67-8787-8E56DF9AB3FEQ38113268-03BA639C-825E-4EE5-BA49-34A4BA1823FC
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Haemophilus influenzae type b conjugate vaccines.
@ast
Haemophilus influenzae type b conjugate vaccines.
@en
Haemophilus influenzae type b conjugate vaccines.
@nl
type
label
Haemophilus influenzae type b conjugate vaccines.
@ast
Haemophilus influenzae type b conjugate vaccines.
@en
Haemophilus influenzae type b conjugate vaccines.
@nl
prefLabel
Haemophilus influenzae type b conjugate vaccines.
@ast
Haemophilus influenzae type b conjugate vaccines.
@en
Haemophilus influenzae type b conjugate vaccines.
@nl
P2093
P2860
P1433
P1476
Haemophilus influenzae type b conjugate vaccines.
@en
P2093
Andrew J Pollard
Dominic F Kelly
E Richard Moxon
P2860
P304
P356
10.1111/J.1365-2567.2004.01971.X
P577
2004-10-01T00:00:00Z